Schonfeld Strategic Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,090
Closed -$155K 2327
2025
Q4
$155K Sell
10,090
-332,593
-97% -$3.66M ﹤0.01% 1757
2025
Q3
$3.4M Buy
342,683
+142,143
+71% +$1.48M 0.02% 772
2025
Q2
$1.99M Sell
200,540
-8,264
-4% -$87.1K 0.01% 991
2025
Q1
$2.71M Sell
208,804
-101,626
-33% -$1.34M 0.02% 809
2024
Q4
$3.96M Buy
310,430
+153,302
+98% +$1.85M 0.02% 582
2024
Q3
$1.75M Sell
157,128
-25,719
-14% -$284K 0.01% 937
2024
Q2
$2.05M Buy
182,847
+52,345
+40% +$609K 0.01% 895
2024
Q1
$1.62M Sell
130,502
-46,504
-26% -$607K 0.01% 1055
2023
Q4
$2.47M Buy
+177,006
New +$2.46M 0.02% 729
2023
Q1
Sell
-47,600
Closed -$506K 2212
2022
Q4
$506K Sell
47,600
-10,150
-18% -$118K ﹤0.01% 1520
2022
Q3
$603K Buy
+57,750
New +$752K 0.01% 1615
2022
Q2
Sell
-34,800
Closed -$377K 2633
2022
Q1
$377K Buy
34,800
+17,500
+101% +$213K ﹤0.01% 1539
2021
Q4
$243K Buy
+17,300
New +$285K ﹤0.01% 1635
2020
Q4
Sell
-84,834
Closed -$367K 1636
2020
Q3
$367K Buy
+84,834
New +$605K 0.01% 1017
2018
Q3
Sell
-48,100
Closed -$733K 847
2018
Q2
$733K Buy
48,100
+21,792
+83% +$377K 0.04% 458
2018
Q1
$522K Buy
26,308
+1,609
+7% +$27.8K 0.04% 466
2017
Q4
$462K Buy
+24,699
New +$496K 0.04% 478
2016
Q4
Sell
-17,070
Closed -$179K 567
2016
Q3
$179K Buy
+17,070
New +$245K 0.03% 377

Other funds holding DVAX

Schonfeld Strategic Advisors's DVAX Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 10,090 shares — an estimated $155K sold.

Schonfeld Strategic Advisors first reported a position in DVAX in Q3 2016 and held it in 18 quarters. The position peaked at $3.96M in Q4 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,090 Dynavax Technologies shares in Q1 2026, an estimated $155K.
  • Schonfeld Strategic Advisors first reported a position in Dynavax Technologies in Q3 2016 and held it in 18 quarters.
  • Schonfeld Strategic Advisors's Dynavax Technologies position peaked at $3.96M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.